Stay updated on Sotatercept in PAH High-Risk Mortality Clinical Trial

Sign up to get notified when there's something new on the Sotatercept in PAH High-Risk Mortality Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sotatercept in PAH High-Risk Mortality Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page now references revision v3.5.2 and no longer references v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-18T13:49:41.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The updates appear to be minor UI and formatting changes to the page; core trial information remains unchanged.
    Difference
    0.1%
    Check dated 2026-04-04T06:08:39.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    No substantive content changes detected between the screenshots; study details and endpoints appear unchanged.
    Difference
    0.1%
    Check dated 2026-03-28T03:23:06.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Revision: v3.5.0 added, replacing the previous Revision: v3.4.3 on the page.
    Difference
    0.1%
    Check dated 2026-03-21T01:01:15.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    Results data and related outcomes were added to the study record, including updates to primary and secondary endpoints. Study completion and primary completion dates were revised.
    Difference
    0.1%
    Check dated 2026-03-13T19:42:35.000Z thumbnail image
  7. Check
    46 days ago
    Change Detected
    Summary
    Expanded the study eligibility to include idiopathic, heritable, drug/toxin-induced, CTD-associated PAH, and post-shunt correction cases, with more detailed baseline criteria and endpoints extending up to ~31 months. Removed the prior requirement of REVEAL Lite 2.0 score ≥9 and the mandate for maximum tolerated background PAH therapy, replacing it with broader inclusion and longer follow-up.
    Difference
    0.6%
    Check dated 2026-03-06T18:09:03.000Z thumbnail image

Stay in the know with updates to Sotatercept in PAH High-Risk Mortality Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sotatercept in PAH High-Risk Mortality Clinical Trial page.